Analysing only the 59 patients admitted within 270 minutes, that is, eligible for thrombolytic therapy, displayed a difference in rate of tPA treatment with 26.7% of patients in the migraine group receiving therapy compared to 59.1% in the no-migraine group (P = 0.03). Here, PLAT is linked to migraine disorder.